University Spin-Off Virmedex Expands Internationally and Prepares New Funding Round
Rapid adoption across United States medical programs validates the cloud educational model, paving the way for a Series A round.
BARCELONA / NEW YORK //
Institutional channels have confirmed the robust international commercial expansion of Virmedex.
The platform has achieved exceptional growth in software license adoption across clinical perfusion schools and surgical departments in both Europe and the United States.
Following this strong market validation, the board has initiated strategic preparations to open a Series A investment round in mid-2026 to fuel further product scaling.
More news
Rapid adoption across United States medical programs validates the cloud educational model, paving the way for a Series A round.
Virmedex announces the growth of its software subscriptions in European hospitals and US universities, moving forward with strategic preparations to open a second funding round in mid-2026.
Read the article →
Dani Tost: ‘Gamifying Simulators with Features Like Scoring Enhances Learning Retention’
Official video interview with CEO Dani Tost, who explains how leveraging gameplay mechanics like leaderboards and immediate feedback drastically boosts clinical learning retention safely.
Read the article →
Video Games, Simulation, and AI to Train the Doctors of the Future
The Caja de Ingenieros Foundation presents its top award to Virmedex in the "Engineering for Social Development" category, celebrating the ethical impact of eliminating patient risks through simulation software.
Read the article →